15-17 June 2011, Cannes, France
The biopharmaceutical conference in Europe
PricewaterhouseCoopers continues to be a key sponsor and supporter of the Biopharmaceutical Conference in Europe and its programme. This exclusive 'by invitation only' event, provides an unique setting for like-mind individuals, at the most senior level to meet and explore new business opportunities in a relaxed, informal setting away from day to day business distractions.
More information at http://www.biopharmaconference.com/.
|
16 June, 2011, New York, USA
2011 Leadership in pharmaceuticals & biotechnology
PricewaterhouseCoopers is a sponsor of the 2011 Leadership in Pharmaceuticals and Biotechnology event hosted by Argyle Executive Forum. This event brings together CEOs and executive from large and midsized pharmaceutical and biotech companies, founders/senior managing partners of investment firms that focus on pharmaceuticals and biotechnology and select advisors.
More information at http://www.argyleforum.com/Events/2011-Leadership-in-Pharmaceuticals-Biotechnology--New-York.
|
27-30 June, BIO 2011, Washington, USA
Annual BIO international conference
The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.
More information at http://convention.bio.org/about_bio_convention.aspx.
|
March 9-11, 2011 Washington, DC, USA
3rd annual summit on disclosure, transparency and aggregate spend for drug, device & biotech companies
PwC is a silver sponsor of The Third Annual Summit on Disclosure Transparency and Aggregate Spend for Drug, Device and Biotech Companies. This year’s event will provide expert advice on how to manage the potential fallout from these disclosures as well as on the myriad operational questions that companies are now confronting. In-house experts will offer first-hand advice on a wide array of emerging best practices ranging from project management to building scalability and sustainability. Panels of outside experts and third parties will examine various aggregate spend technology solutions. The Summit will also feature senior regulators from the HHS Office of Inspector General (OIG) and other agencies, as well as former Justice Department attorneys, on how the government is likely to use these data.
More information at http://www.disclosuresummit.com/
|
14-15 March 2011, Philadelphia, USA
7th annual pharmaceutical/ biotech accounting and reporting congress
This meeting provides updates on changing regulations, technical accounting, auditing and financial reporting best practices. Most importantly, it is uniquely tailored for the specific challenges and requirements of pharmaceutical and biotech companies.
More information at http://www.cbinet.com/show_conference.cfm?confcode=PC11139
|
14-17 October 2010, Laguna Beach, California, USA
17th annual Phoenix conference
The Medical Device & Diagnostic Conference for Chief Executive Officers
PwC's Pharmaceutical & Life Sciences Sector Group is a founder and key sponsor of the 17th Annual Phoenix Conference. This invitation-only medical device conference provides an outstanding opportunity in a private and exclusive setting for networking and partnering. The agenda will include high-level panel discussions with keynotes from industry and academic leaders.
More information at http://www.wsgr.com/news/phoenix/
|
18-20 October 2010, Washington DC, USA
AdvaMed 2010
AdvaMed 2010, of which PwC is a sponsor, is the premier MedTech Conference for CEOs, business executives, policy-makers, financiers, media, and industry stakeholders from around the world.
Doug Mowen, a managing director in our Advisory practice will be presenting.
More information at http://www.advamed2010.com/
|
20-22 October 2010, Washington DC, USA
11th annual pharmaceutical regulatory and compliance congress and best practices forum
We are proud to be the lead sponsor of the 11th Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum at the JW Marriott Hotel, in Washington DC on October 20-22, 2010.
The Congress brings together many of the nation’s top pharmaceutical compliance executives and regulators to discuss current and future compliance laws and regulations, and enforcement initiatives affecting the pharmaceutical industry. Jonathan Kellerman, Partner, Global Pharmaceutical Advisory Services Group, is a featured speaker.
More information at http://www.pharmacongress.com/
|
27-28 September 2010, Burlingame, California, USA
The Burrill personalized medicine meeting
The 6th Annual Burrill Personalized Medicine Meeting is a two-day event, which encompasses detailed discussions on the whole spectrum of personalized medicine – from personalized medicine prediction to prevention to personalized care – provides attendees with a detailed “window” into the personalized medicine world and the 2010 challenges and opportunities this paradigm presents.
PwC is a sponsor of the 2010 conference and Gerald McDougal, Partner, Pharmaceutical and Life Sciences Group will be a speaker.
More information at http://www.burrillandco.com/personalized_medicine_2010/
|
13-16 September 2010, Arlington, Virginia, USA
ADAPT 2010 congress – accelerating development and advancing personalised therapy
Gerry McDougall, Partner, Personalized Medicine and Health Sciences Practices, will present a session on the value proposition of companion diagnostics for the pharmaceutical industry.
More information at http://www.adaptcongress.com/
|
20-21 September 2010, Boston, USA
Personalized and translational medicine summit 2010
PwC is a supporting partner for the 2010 Personalized and Translational Medicine Summit. This event is dedicated in fostering a meeting platform and cover all the aspects of this complex endeavour, with the ultimate goal of take product development to the next level. Matthew Rosamond, Director, will be speaking.
More information at http://www.eyeforpharma.com/translationalmedicine/index.shtml
|
22 June 2010
2010 leadership in pharmaceuticals and biotechnology event
PwC is a sponsor of the 2010 Leadership in Pharmaceuticals and Biotechnology event hosted by Argyle Executive Forum The event will take place in Manhattan. The event brings together CEOs and executive from large and midsized pharmaceutical and biotech companies, founders/senior managing partners of investment firms that focus on pharmaceuticals and biotechnology and select advisors.
More information at http://www.argyleforum.com/events/eventimages/06.22.10/main.html
|
16-18 June 2010, Monte Carlo
The biopharmaceutical conference in Europe
PwC continues to be a key sponsor and supporter of the Biopharmaceutical Conference in Europe and its programme. This exclusive 'by invitation only' event, provides an unique setting for like-mind individuals, at the most senior level to meet and explore new business opportunities in a relaxed, informal setting away from day to day business distractions.
More information at http://www.biopharmaconference.com or contact Art Karacsony and Marina Bello Valcarce
|
19-20 May 2010, Minneapolis, USA
9th annual IBF Medtech investing conference
Annual med-device investors conference to unite the most active investors with entrepreneurs, managers, and strategic players from the medical device industry to network and exchange information on current/future trends, challenges, and areas of opportunity.
More information at http://www.medtechconference.com
|
17-18 May 2010, Berlin, Germany
The fourth international pharmaceutical regulatory and compliance congress & Best practices forum
Sponsored by The Pharmaceutical Compliance Forum
PwC's Global Pharmaceutical & Life Sciences industry group are sponsors of the 2010 congress. The congress brings together leading industry executives, government regulators and noted industry consultants to discuss changes in the pharmaceutical regulatory landscape.
More information at www.internationalpharmacongress.com or contact Marina Bello Valcarce
|
3-6 May 2010, BIO 2010, Chicago, USA
Annual BIO international conference
The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.
More information at http://bio2010.org/
|
3-5 May 2010, Berlin, Germany
2010 international medical device industry compliance, regulatory and IP conference
PwC Global Pharmaceutical & Life Sciences industry group are Gold sponsors of the 2010 conference. The event brings together leading industry executives, government regulators and noted industry consultants to discuss changes in the pharmaceutical regulatory landscape.
More information at www.advamed.org or contact Marina Bello Valcarce
|
3-5 March 2010, Washington DC, USA
Second annual summit on disclosure, transparency and aggregate spend for drug, device and biotech companies
The focus on transparency and disclosure for medical device, biotech and pharmaceutical companies is at an all-time high. There are a number of state laws already on the books that require manufacturers to gather, aggregate, report and disclose financial payments to physicians. The 2nd Annual Summit on Sales & Marketing Disclosure for Drug, Device and Biotech Companies covers the significant implications of an evolving set of sales and marketing disclosure requirements.
More information at http://www.disclosuresummit.com
|
10 February 2010, 30 March 2010, 21 April 2010, Palo Alto, CA
Innovator's workbench
The Innovator's Workbench features top innovators in the biomedical technology field. In this series you'll hear them discuss their process of identifying major critical needs, creating new technologies and how they implemented innovations in patient care. The Workbench events showcase the people who have built the industry and expose the community to their story and lessons learned.
More information at http://biodesign.stanford.edu/bdn/networking/workbench.jsp
|
1-3 December 2010, Florence, Italy
6th Bohemian medical device summit
PwC is one of the founders of this by invitation-only conference for CEOs from medical device companies in Europe. The event provides a private and exclusive setting for networking and partnering with an agenda that includes high-level panel discussions and keynote presentations from industry and academic leaders.
More information at http://www.bohemiansummit.com/
|
14-15 February 2011, New York, USA
BIO CEO and investor conference
PwC is a sponsor of this event for Biotech and device CEOs and key Venture Capitalists to build networks with key targets and clients
More information at http://www.bio.org/events/
|
14 - 15 March 2011, Philadelphia, USA
7th annual pharmaceutical/ biotech accounting and reporting congress
Industry-specific best practices for sound accounting, efficient internal controls and compliant financial reporting
This meeting provides updates on changing regulations, technical accounting, auditing and financial reporting best practices. Most importantly, it is uniquely tailored for the specific challenges and requirements of pharmaceutical and biotech companies.
More information at http://www.cbinet.com/show_conference.cfm?confCode=PC11139
|
|
